Search - tctmd.com

Displaying 121 - 140 of 204

Sort: Relevancy | Date

News Industry News

iVascular completes recruitment of patients for its ANCHOR clinical trial of the sirolimus eluting stent ANGIOLITE

May 19, 2016

News Industry News

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

February 01, 2016

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

News Daily News

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Todd Neale

November 16, 2015

Presentation TCT 2015

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

Presenter: Sigmund Silber, Philip M. Urban, David E. Kandzari

October 13, 2015

News Industry News

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

October 12, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Industry News

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

September 21, 2015

News Daily News

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

Yael L. Maxwell

September 14, 2015

News Industry News

First Patient Enrolled in CeloNova’s e-COBRA Clinical Registry

September 14, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Industry News

Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology

July 20, 2015

News Industry News

U.S. to vie with India for top bioabsorbable stent market after FDA approval

June 25, 2015

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting Stent in United States

March 12, 2015

News Daily News

MASTER: Potential Mortality Advantage With Mesh-Covered Stent in STEMI Patients at 1 Year

Yael L. Maxwell

February 19, 2015

News Daily News

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

Yael L. Maxwell

January 28, 2015

News Daily News

TE-PROVE: Estudio Europeo Post-Aprobación de SLP Confirma la Seguridad en Pacientes No Seleccionados

Yael L. Maxwell

January 28, 2015

Presentation

TE-PROVE: 1-year Outcomes in Unselected Patients Treated With a Thin-Strut, Platinum-Chromium PES

Presenter: C. Tamburino

January 14, 2015

Advertisement

iVascular completes recruitment of patients for its ANCHOR clinical trial of the sirolimus eluting stent ANGIOLITE

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

Boston Scientific Announces Scheduled Presentations At TCT 2015

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

First Patient Enrolled in CeloNova’s e-COBRA Clinical Registry

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology

U.S. to vie with India for top bioabsorbable stent market after FDA approval

Trials Explore the Potential of Biodegradable-Polymer Stents

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting Stent in United States

MASTER: Potential Mortality Advantage With Mesh-Covered Stent in STEMI Patients at 1 Year

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

TE-PROVE: Estudio Europeo Post-Aprobación de SLP Confirma la Seguridad en Pacientes No Seleccionados

TE-PROVE: 1-year Outcomes in Unselected Patients Treated With a Thin-Strut, Platinum-Chromium PES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content